Abstract
Discontinuation of anti-CCL2 therapy augments lethal breast cancer metastasis in mice.
©2014 American Association for Cancer Research.
2014
You do not currently have access to this content.
Skip Nav Destination
Article navigation
1 December 2014
Research Watch|
December 03 2014
Interruption of CCL2 Inhibition Enhances Metastatic Disease Available to Purchase
Cancer Discov (2014) 4 (12): 1364.
RSS Feeds